Exhibit 10.1
EXECUTION
COPY
EBIX, INC.
SECURED CONVERTIBLE
NOTE
PURCHASE AGREEMENT
July 11, 2008
SECURED CONVERTIBLE NOTE PURCHASE
AGREEMENT
THIS SECURED
CONVERTIBLE NOTE PURCHASE AGREEMENT (the “ Agreement
”) is made effective as of July 11, 2008, by and between
Ebix, Inc., a Delaware corporation (the “ Company
”), and Whitebox VSC Ltd., a limited partnership organized
under the laws of the British Virgin Islands (the “
Investor ”), with respect to the following
recitals.
RECITALS
A.
The Company desires to issue and sell and the Investor desires to
purchase secured convertible promissory notes in substantially the
form attached to this Agreement as Exhibit A
(collectively, the “ Notes ”), which shall be
convertible on the terms stated therein into common stock, par
value $.10 per share (the “ Common Stock ”), of
the Company; and
B.
As a further inducement for Investor to purchase the Notes, the
Company desires to provide a security interest in all assets of the
Company as collateral to further secure the performance of the
Company’s obligations under the Notes, as set forth in that
certain Security Agreement to be entered into between the Company
and the Investor within thirty (30) days after the date hereof (the
“ Security Agreement ”).
AGREEMENT
NOW, THEREFORE , in
consideration of the respective representations, warranties,
covenants and agreements contained herein, and for other valuable
consideration, the receipt and adequacy of which is hereby
acknowledged, the parties hereto agree as follows:
ARTICLE I
DEFINITIONS
Section 1.1 Specific
Definitions . As used in this Agreement, the following
terms shall have the meanings set forth or as referenced
below:
“
Action ” shall have the meaning ascribed to such term
in Section 4.10.
“
Affiliate ” of a specified person (natural or
juridical) means a person that directly, or indirectly through one
or more intermediaries, controls, or is controlled by, or is under
common control with, that person, as such terms are used in and
construed under Rule 405 under the Securities Act. With
respect to the Investor, any investment fund or managed account
that is managed on a discretionary basis by the same investment
manager as the Investor will be deemed to be an Affiliate of the
Investor.
“
Agreement ” means this Agreement and all Exhibits and
Schedules hereto.
“
Closing ” shall have the meaning ascribed to such term
in Section 3.1.
“ Closing
Date ” shall have the meaning ascribed to such term in
Section 3.1.
“
Code ” shall have the meaning ascribed to such term in
Section 4.35.
“ Common
Stock ” means the Company’s common stock, par value
$0.10 per share.
“
Conversion Price ” means the conversion price in
effect on any given date, which initially shall be equal to $84.00,
but which shall be subject to adjustment as described herein and in
the Note.
“ Common
Stock Equivalents ” means any securities of the Company
or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation,
any debt, preferred stock, rights, options, warrants or other
instrument that is at any time convertible into or exercisable or
exchangeable for, or otherwise entitles the holder thereof to
receive, Common Stock.
“
Conversion Shares ” or “ Shares ”
means the shares of Common Stock issued or issuable upon conversion
of any of the Convertible Note.
“
Convertible Note ” or “ Note ”
means the promissory note, in the form attached hereto as
Exhibit A , to be issued by the Company to the
Investor.
“
Disclosure Schedules ” means the Disclosure Schedules
of the Company delivered concurrently herewith.
“
Effective Date ” means the date that the Registration
Statement filed by the Company is first declared effective by the
SEC.
“
Environmental Laws or Regulations ” means any federal,
state or local statute, law, ordinance or regulation that relates
to or deals with hazardous substances, human health or the
environment, and all regulations promulgated by a regulatory body
pursuant to any of the foregoing statutes, laws, regulations, or
ordinances.
“
ERISA ” shall have the meaning ascribed to such term
in Section 4.35.
“
Evaluation Date ” shall have the meaning ascribed to
such term in Section 4.18.
“
Exchange Act ” shall mean the Securities Exchange Act
of 1934, as amended to date.
“ Exempt
Issuance ” means (a) the vesting of shares of Common
Stock or options to employees, officers, consultants or directors
of the Company pursuant to the Company’s 1996 Stock Option
Plan, as amended (provided that any such vesting shall not exceed
10% of the Company’s outstanding shares and/or options, in
the aggregate, in any twelve-month period), (b) the issuance
of securities upon the exercise or exchange of or conversion of any
securities issued pursuant to the Purchase Agreement and/or other
securities exercisable or exchangeable for or convertible into
shares of Common Stock issued and outstanding on the date of this
Agreement, provided that such securities have not been amended
since the date of this Agreement to increase the number of such
securities or to decrease the exercise, exchange or conversion
price of such securities, and (c) the issuance of securities
issued pursuant to acquisitions or strategic transactions approved
by a majority of the disinterested directors of the
2
Company, provided
any such issuance shall only be to a person which is, itself or
through its subsidiaries, an operating company in a business
synergistic with or complementary to the business of the Company
and in which the Company receives benefits in addition to the
investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of
raising capital or to an entity whose primary business is investing
in securities.
“
Financial Statements ” means the Company’s
audited financial statements as of and for the year ended
December 31, 2007 and unaudited quarterly financial statements
of the Company for the quarter ended March 31,
2008.
“
GAAP ” shall have the meaning ascribed to such term in
Section 4.8.
“
Guaranty ” means that certain Guaranty to be entered
into by and among the Company and certain of its Affiliates in
favor of the Investor within thirty (30) days after the Closing
Date.
“
Indemnifiable Losses ” shall have the meaning ascribed
to such term in Section 9.1.
“
Intellectual Property ” means (i) all proprietary
rights, privileges and priorities provided under U.S., state and
foreign law relating to U.S. and foreign patents and patent
applications, trademarks, service marks and registrations thereof
and applications therefor, copyrights and copyright registrations
and applications, mask works and registrations thereof, know-how,
and trade secrets; (ii) proprietary inventions, discoveries,
ideas, technology, data, information, and processes;
(iii) proprietary drawings, designs, licenses, computer
programs and software, and technical information including but not
limited to proprietary information embodied in material
specifications, processing instructions, equipment specifications,
product specifications, confidential data, electronic files,
research notebooks, invention disclosures, research and development
reports and the like related thereto; and (iv) all amendments,
modifications, and improvements to any of the foregoing.
“
Intellectual Property Rights ” shall have the meaning
ascribed to such term in Section 4.15.
“
Knowledge ” means actual knowledge of a fact or the
knowledge which such person could reasonably be expected to have
based on reasonable inquiry. The knowledge of an entity shall
include the knowledge of the individuals who are executive officers
of such entity at the time in question.
“ Legend
Removal Date ” shall have the meaning ascribed to such
term in Section 6.10(c).
“
Liens ” means liens, mortgages, charges, security
interests, claims, voting trusts, pledges, encumbrances, options,
assessments, restrictions, or third-party or spousal interests of
any nature.
“
Mandatory Conversion Notice ” shall have the meaning
ascribed to such term in Section 2.2(b).
“
Mandatory Conversion Notice Date ” shall have the
meaning ascribed to such term in Section 2.2(b).
3
“
Material Adverse Effect ” means any effect that may be
materially adverse to (a) the business, operations, results of
operations, prospects, assets (including intangible assets),
liabilities or condition (financial or otherwise) of the Company
and its Affiliates, taken as a whole, or (b) the ability of
the Company to perform its obligations under this Agreement or any
of the Transaction Documents or any other agreement or instrument
to be entered into in connection with this Agreement.
“
Material Permits ” shall have the meaning ascribed to
such term in Section 4.13.
“
Note ” shall have the meaning ascribed to such term in
Section 2.1.
“
Person ” means an individual or corporation,
partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of
any kind.
“
Plan ” or “ Plans ” shall have the
meaning ascribed to such term in Section 4.35.
“
Proceeding ” means an action, claim, suit,
investigation or proceeding (including, without limitation, an
informal investigation or partial proceeding, such as a
deposition), whether commenced or threatened.
“ Product
Liability ” means any liability, claim or expense,
including but not limited to attorneys’ fees and medical
expenses, arising in whole or in part out of a breach of any
express or implied product warranty by the Company, strict
liability in tort, negligent manufacture of product, negligent
provision of services, product recall, or any other allegation of
liability arising from the design, testing, manufacture, packaging,
labeling (including instructions for use), or sale of
products.
“
Prospectus ” shall have the meaning ascribed to such
term in Section 9.1.
“
Purchase Price ” shall have the meaning ascribed to
such term in Section 2.1.
“
Purchased Securities ” means the Convertible Note and
the Conversion Shares.
“
Registration Statement ” means a registration
statement meeting the requirements set forth in Section 6.12
below and covering the resale by the Investor of the Conversion
Shares. The term “Registration Statement” shall
include any preliminary or final prospectus, exhibit, supplement or
amendment included in or relating to such Registration
Statement.
“
Required Approvals ” shall have the meaning ascribed
to such term in Section 4.5.
“
Required Minimum ” means, as of any date, the maximum
aggregate number of shares of Common Stock then issued or
potentially issuable in the future pursuant to the Transaction
Documents, including any Conversion Shares issuable upon exercise
or conversion in full of all Notes, ignoring any conversion or
exercise limits set forth therein.
4
“
Rule 144 ” means Rule 144 promulgated by the
SEC pursuant to the Securities Act, as such Rule may be
amended from time to time, or any similar rule or regulation
hereafter adopted by the SEC having substantially the same effect
as such Rule.
“
Schedule of Exceptions ” shall have the meaning
ascribed to such term in Article 4.
“ SEC
” means the United States Securities and Exchange Commission
or any other federal agency at the time administering the
Securities Act.
“ SEC
Reports ” shall have the meaning ascribed to such term in
Section 4.8.
“
Securities Act ” means the United States Securities
Act of 1933, as amended, and all regulations promulgated
thereunder.
“
Security Agreement ” means the security agreement to
be entered into by and between the Company and the Investor within
thirty (30) days after the Closing Date.
“ Short
Sales ” means all “short sales” as defined in
Rule 200 of Regulation SHO under the Exchange Act (but shall
not be deemed to include the location and/or reservation of
borrowable shares of Common Stock).
“
Subsidiary ” means any subsidiary of the Company as
set forth on Schedule 4.1 and shall, where applicable,
include any subsidiary of the Company formed or acquired after the
date hereof.
“
Threshold Period ” shall have the meaning ascribed to
such term in Section 2.2(b).
“ Trading
Day ” means a day on which the Nasdaq Stock Market (or
such other Trading Market on which the Company’s Common Stock
is then traded) is open for trading.
“ Trading
Market ” means the following markets or exchanges on
which the Common Stock is listed or quoted for trading on the date
in question: the American Stock Exchange, the Nasdaq Capital
Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
the New York Stock Exchange or the OTC Bulletin Board.
“
Transaction Documents ” means the Notes, the Security
Agreement, the Guaranty, the Security Agreement, any Intercreditor
Agreement as may be required to be delivered hereunder and such
other documents, instruments and agreements executed in connection
with the consummation of the transactions contemplated
hereby.
“
VWAP ” means, for any date, the price determined by
the first of the following clauses that applies: (a) if the
Common Stock is then listed or quoted on a Trading Market, the
daily volume weighted average price of the Common Stock for such
date (or the nearest preceding date) on the Trading Market on which
the Common Stock is then listed or quoted for trading as reported
by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New
York City time) to 4:02 p.m. (New York City time); (b)
if the OTC Bulletin Board is not a Trading Market, the volume
weighted average price of the Common Stock for such date (or the
nearest preceding date) on the OTC Bulletin Board; (c) if the
Common Stock is not then quoted for trading on the
5
OTC Bulletin Board
and if prices for the Common Stock are then reported in the
“Pink Sheets” published by Pink Sheets, LLC (or a
similar organization or agency succeeding to its functions of
reporting prices), the most recent bid price per share of the
Common Stock so reported; or (d) in all other cases, the fair
market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the Holder and
reasonably acceptable to the Company.
Section 1.2 Definitional
Provisions .
(a) The words “hereof,”
“herein,” and “hereunder” and words of
similar import, when used in this Agreement, shall refer to this
Agreement as a whole and not to any particular provisions of this
Agreement.
(b) The terms defined in the
singular shall have a comparable meaning when used in the plural,
and vice versa. Terms referring to a masculine gender shall
be deemed to refer to the feminine or neuter genders, as
applicable.
(c) References to an
“Exhibit” or to a “Schedule” are, unless
otherwise specified, to one of the Exhibits or Schedules attached
to or referenced in this Agreement, and references to an
“Article” or a “Section” are, unless
otherwise specified, to one of the Articles or Sections of this
Agreement.
(d) The term “person”
includes any individual, partnership, joint venture, corporation,
limited liability company, trust, entity, unincorporated
organization or government or any department or agency
thereof.
(e) The term “dollars”
or “$” shall refer to the currency of the United States
of America.
(f) All references to time
shall refer to Minneapolis, Minnesota time.
ARTICLE II
PURCHASE AND SALE OF CONVERTIBLE NOTES
Section 2.1 Purchase and Sale of
Notes . Subject to the terms and conditions of this
Agreement, the Investor agrees to purchase at the Closing, and the
Company agrees to sell and issue to the Investor at the Closing, a
Note, in substantially the form attached hereto as
Exhibit A , in the original principal amount of
$15,000,000 (the “ Note ”), at a purchase price
equal to 100% of the principal amount thereof (the “
Purchase Price ”). The Note will be secured
pursuant to the Security Agreement.
Section 2.2 Note Conversion
.
(a)
Optional Conversion . The Investor may, at its option,
purchase shares of the Company’s Common Stock by converting
amounts outstanding under the Note or, if applicable, the
Additional Note and the Subsequent Note, at the applicable
Conversion Price as provided therein (in each case, a “
Note Conversion Closing ”). At each Note
Conversion Closing, the Company shall issue certificates
representing any shares
6
purchased under this Section 2.2 in a form
acceptable to the Investor and Investor’s counsel, and the
Investor shall pay the Conversion Price of $84.00 per share
(subject to adjustment as provided therein) for such shares by
surrendering the applicable Note(s) to the
Company.
(b)
Mandatory Conversion . Notwithstanding anything herein
to the contrary, if after the Closing Date, (i) the average
price of the Company’s Common Stock on the Trading Market
exceeds $168.00 per share (subject to adjustment for stock splits,
dividends and other appropriate adjustments) for any 30 consecutive
Trading Days (the “ Threshold Period ”), the
Company shall have the option, within two (2) Trading Days
after the end of any such Threshold Period, deliver a written
notice to the Investor (a “ Mandatory Conversion
Notice ” and the date of such notice, the “
Mandatory Conversion Notice Date ”) to cause the
Investor to surrender the Note and seek immediate conversion of the
remaining amounts due under the Note on such Mandatory Conversion
Notice Date into the Company’s Common Stock at the conversion
price of $84.00 per share (subject to adjustment as provided under
the Note).
Section 2.3 Use of Proceeds
. The Company shall use the cash proceeds of the sale of the
Notes (a) for the Company’s strategic acquisition and
working capital needs and (b) to pay any legal fees and
expenses incurred in connection with the drafting, negotiation, due
diligence and execution of this Agreement and the other Transaction
Documents (including those documents delivered in connection with
the issuance of the Note and the Conversion Shares to the Investor
on the Closing Date) (which, in the case of counsel to Investors,
shall be limited to $30,000 in accordance with the terms set forth
in Section 11.7 below).
ARTICLE III
THE CLOSING
Section 3.1 Closing .
The purchase and sale of the Notes shall take place at the offices
of the Company, at 10:00 a.m., on July 11, 2008, or such
other time as may be designated by the Company in writing (the
“ Closing ”). At the Closing, the Company
shall deliver to the Investor the Note that the Investor is
purchasing against delivery to the Company by the Investor of a
check or wire transfer in the amount of $15,000,000.00 payable to
the Company’s order (or by wire of funds in such amount to
the Company’s designated bank account).
Section 3.2 Closing
Deliveries .
(a) Company Deliveries
. On the Closing Date, the Company shall deliver or cause to
be delivered to the Investor the following:
(i)
this Agreement duly executed by the Company; and
(ii)
a Note registered in the name of the Investor in the principal
amount of $15,000,000.
7
(b) Investor Deliveries
. On the Closing Date, the Investor shall deliver or cause to
be delivered to the Company the following:
(i)
this Agreement duly executed by the Investor; and
(ii)
the payment of the Purchase Price by the Investor, in the manner
specified in Section 3.1 above.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
Attached hereto as
Schedule A is the Schedule of Exceptions containing sections
numbered to correspond to the sections of this Article 4 (the
“ Schedule of Exceptions ”). Except as
specifically set forth in the corresponding section of such
Schedule of Exceptions (or in any other section of the Schedule of
Exceptions so long as the applicability of such disclosure to the
particular representation and warranty which such disclosure is
intended to modify is reasonably apparent), the Company and its
Affiliates hereby represents and warrants to the Investor as
follows as of the date hereof and as of the Closing
Date:
Section 4.1 Subsidiaries
. All of the direct and indirect subsidiaries (the “
Subsidiaries ”) of the Company are set forth on
Schedule 4.1 . The Company owns, directly or
indirectly, all of the capital stock or other equity interests of
each Subsidiary free and clear of any Liens, and all of the issued
and outstanding shares of capital stock of each Subsidiary are
validly issued and are fully paid, non-assessable and free of
preemptive and similar rights to subscribe for or purchase
securities.
Section 4.2 Organization and
Qualification . The Company and each of the Subsidiaries
is an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of
its incorporation or organization (as applicable), with the
requisite power and authority to own and use its properties and
assets and to carry on its business as currently conducted.
Neither the Company nor any Subsidiary is in violation or default
of any of the provisions of its respective certificate or articles
of incorporation, bylaws or other organizational or charter
documents. Each of the Company and the Subsidiaries is duly
qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the
nature of the business conducted or property owned by it makes such
qualification necessary, except where the failure to be so
qualified or in good standing, as the case may be, could not have
or reasonably be expected to result in a Material Adverse Effect,
and no Proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or
curtail such power and authority or qualification.
Section 4.3 Authorization;
Enforcement . The Company has the requisite corporate
power and authority to enter into and to consummate the
transactions contemplated by each of the Transaction Documents and
otherwise to carry out its obligations hereunder and
thereunder. The execution and delivery of each of the
Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly
authorized by all necessary action on the part of the Company and
no further action is required by the Company, its board of
directors or its shareholders in connection therewith other than
in
8
connection with the
Required Approvals (as defined in Section 4.5 below).
Each Transaction Document has been (or upon delivery will have
been) duly executed by the Company and, when delivered in
accordance with the terms hereof and thereof, will constitute the
valid and binding obligation of the Company enforceable against the
Company in accordance with its terms except (i) as limited by
general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application
affecting enforcement of creditors’ rights generally,
(ii) as limited by laws relating to the availability of
specific performance, injunctive relief or other equitable remedies
and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.
Section 4.4 No Conflicts
. The execution, delivery and performance of the Transaction
Documents by the Company, the issuance and sale of the Purchased
Securities and the consummation by the Company of the other
transactions contemplated hereby and thereby do not and will not
(i) conflict with or violate any provision of the
Company’s or any Subsidiary’s certificate or articles
of incorporation, bylaws or other organizational or charter
documents, or (ii) conflict with, or constitute a default (or
an event that with notice or lapse of time or both would become a
default) under, result in the creation of any Lien upon any of the
properties or assets of the Company or any Subsidiary, or give to
others any rights of termination, amendment, acceleration or
cancellation (with or without notice, lapse of time or both) of,
any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other
understanding to which the Company or any Subsidiary is a party or
by which any property or asset of the Company or any Subsidiary is
bound or affected, or (iii) subject to the Required Approvals
(as defined in Section 4.5 below), conflict with or result in
a violation of any law, rule, regulation, order, judgment,
injunction, decree or other restriction of any court or
governmental authority to which the Company or any Subsidiary is
subject (including federal and state securities laws and
regulations), or by which any property or asset of the Company or a
Subsidiary is bound or affected; except in the case of each of
clauses (ii) and (iii), such as could not have or reasonably
be expected to result in a Material Adverse Effect.
Section 4.5 Filings, Consents and
Approvals . The Company is not required to obtain any
consent, waiver, authorization or order of, give any notice to, or
make any filing or registration with, any court or other federal,
state, local or other governmental authority or other Person in
connection with the execution, delivery and performance by the
Company of the Transaction Documents, other than (i) filings
required pursuant to Section 6.14 of this Agreement,
(ii) the filing with the SEC of the Registration Statement,
(iii) application(s) to each applicable Trading Market
for the listing of the Securities for trading thereon in the time
and manner required thereby, and (iv) the filing of
Form D with the SEC and such filings as are required to be
made under applicable state securities laws (collectively, the
“ Required Approvals ”).
Section 4.6 Issuance of the
Securities . The Purchased Securities are duly authorized
and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid
and nonassessable, free and clear of all Liens imposed by the
Company other than restrictions on transfer provided for in the
Transaction Documents. The Conversion Shares, when issued in
accordance with the terms of the Transaction Documents, will be
validly issued, fully paid and nonassessable, free and clear of all
Liens imposed by the Company other than restrictions on transfer
provided for in the Transaction Documents. The
9
Company has reserved
from its duly authorized capital stock the maximum number of shares
of Common Stock issuable pursuant to this Agreement and the other
Transaction Documents.
Section 4.7 Capitalization
. The capitalization of the Company is as set forth on the
Schedule of Exceptions, which shall also include the number of
shares of Common Stock owned of record, and, to the knowledge of
the Company, beneficially, by Affiliates of the Company as of the
date hereof. The Company has not issued any capital stock since its
most recently filed periodic report under the Exchange Act, other
than the exercise of employee stock options under the
Company’s stock option plans, the issuance of shares of
Common Stock to employees pursuant to the Company’s employee
stock purchase plans and pursuant to the conversion or exercise of
Common Stock Equivalents outstanding as of the date of the most
recently filed periodic report under the Exchange Act. No
Person has any right of first refusal, preemptive right, right of
participation, or any similar right to participate in the
transactions contemplated by the Transaction Documents.
Except as set forth on the Schedule of Exceptions or as a result of
the purchase and sale of the Purchased Securities, there are no
outstanding options, warrants, scrip rights to subscribe to, calls
or commitments of any character whatsoever relating to, or
securities, rights or obligations convertible into or exercisable
or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock, or contracts,
commitments, understandings or arrangements by which the Company or
any Subsidiary is or may become bound to issue additional shares of
Common Stock or Common Stock Equivalents. The issuance and
sale of the Purchased Securities will not obligate the Company to
issue shares of Common Stock or other securities to any Person
(other than the Investor) and will not result in a right of any
holder of Company securities to adjust the exercise, conversion,
exchange or reset price under any of such securities. All of the
outstanding shares of capital stock of the Company are validly
issued, fully paid and nonassessable, have been issued in
compliance with all federal and state securities laws, and none of
such outstanding shares was issued in violation of any preemptive
rights or similar rights to subscribe for or purchase
securities. No further approval or authorization of any
shareholder, the Board of Directors of the Company or others is
required for the issuance and sale of the Purchased
Securities. There are no stockholder agreements, voting
agreements or other similar agreements with respect to the
Company’s capital stock to which the Company is a party
(other than those contemplated in connection with the Transaction
Documents) or, to the knowledge of the Company, between or among
any of the Company’s shareholders.
Section 4.8 SEC Reports;
Financial Statements . The Company has filed all reports,
schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act,
including pursuant to Section 13(a) or
15(d) thereof, for the two years preceding the date hereof (or
such shorter period as the Company was required by law or
regulation to file such material) (the foregoing materials,
including the exhibits thereto and documents incorporated by
reference therein, being collectively referred to herein as the
“ SEC Reports ”) on a timely basis or has
received a valid extension of such time of filing and has filed any
such SEC Reports prior to the expiration of any such
extension. As of their respective dates, the SEC Reports
complied in all material respects with the requirements of the
Securities Act and the Exchange Act, as applicable, and none of the
SEC Reports, when filed, contained any untrue statement of a
material fact or omitted to state a material fact required to be
stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were
made, not misleading. The financial statements of the Company
included
10
in the SEC Reports
comply in all material respects with applicable accounting
requirements and the rules and regulations of the SEC with
respect thereto as in effect at the time of filing. Such
financial statements have been prepared in accordance with United
States generally accepted accounting principles applied on a
consistent basis during the periods involved (“ GAAP
”), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial
statements may not contain all footnotes required by GAAP, and
fairly present in all material respects the financial position of
the Company and its consolidated subsidiaries as of and for the
dates thereof and the results of operations and cash flows for the
periods then ended, subject, in the case of unaudited statements,
to normal, immaterial, year-end audit adjustments.
Section 4.9 Material Changes;
Undisclosed Events, Liabilities or Developments . Since
the date of the latest audited financial statements included within
the SEC Reports, except as specifically disclosed in a subsequent
SEC Report filed prior to the date hereof, (i) there has been
no event, occurrence or development that has had or that could
reasonably be expected to result in a Material Adverse Effect,
(ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) increasing its revolving line of
credit with LaSalle Bank N.A. to a total of $25,000,000,
(B) trade payables and accrued expenses incurred in the
ordinary course of business consistent with past practice and
(C) liabilities not required to be reflected in the
Company’s financial statements pursuant to GAAP or disclosed
in filings made with the SEC, (iii) the Company has not
altered its method of accounting, (iv) the Company has not
declared or made any dividend or distribution of cash or other
property to its shareholders or purchased, redeemed or made any
agreements to purchase or redeem any shares of its capital stock
and (v) the Company has not issued any equity securities to
any officer, director or Affiliate, except pursuant to existing
Company stock option plans. The Company does not have pending
issues before the SEC except a question regarding the change of
control provision in the previous convertible note signed with the
investor that the investor has retroactively deleted. .
Except for the issuance of the Purchased Securities contemplated by
this Agreement or as set forth on Schedule 4.9 , no event,
liability or development has occurred or exists with respect to the
Company or its Subsidiaries or their respective business,
properties, operations or financial condition, that would be
required to be disclosed by the Company under applicable securities
laws at the time this representation is made or deemed made that
has not been publicly disclosed at least 1 Trading Day prior to the
date that this representation is made.
Section 4.10 Litigation
. There is no action, suit, inquiry, notice of violation,
proceeding or investigation pending or, to the knowledge of the
Company, threatened against or affecting the Company, any
Subsidiary or any of their respective properties before or by any
court, arbitrator, governmental or administrative agency or
regulatory authority (federal, state, county, local or foreign)
(collectively, an “ Action ”) which
(i) adversely affects or challenges the legality, validity or
enforceability of any of the Transaction Documents or the Purchased
Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material
Adverse Effect. Neither the Company nor any Subsidiary, nor
any director or officer thereof, is or has been the subject of any
Action which has resulted in a final judgment involving a claim of
violation of or liability under federal or state securities laws or
a claim of breach of fiduciary duty. There has not been, and
to the knowledge of the Company, there is not pending or
contemplated, any investigation by the SEC involving the Company or
any current or former director or officer of the Company. The
SEC has not issued any stop order or other order
11
suspending the
effectiveness of any registration statement filed by the Company or
any Subsidiary under the Exchange Act or the Securities
Act.
Section 4.11 Labor Relations
. No material labor dispute exists or, to the knowledge of
the Company, is imminent with respect to any of the employees of
the Company which could reasonably be expected to result in a
Material Adverse Effect. None of the Company’s or its
Subsidiaries’ employees is a member of a union that relates
to such employee’s relationship with the Company or such
Subsidiary, and neither the Company nor any of its Subsidiaries is
a party to a collective bargaining agreement. No executive
officer, to the knowledge of the Company, is, or is now expected to
be, in violation of any material term of any employment contract,
confidentiality, disclosure or proprietary information agreement or
non-competition agreement, or any other contract or agreement or
any restrictive covenant in favor of any third party, and the
continued employment of each such executive officer does not
subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and
its Subsidiaries are in compliance with all U.S. federal, state,
local and foreign laws and regulations relating to employment and
employment practices, terms and conditions of employment and wages
and hours, except where the failure to be in compliance could not,
individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.
Section 4.12 Compliance
. Neither the Company nor any Subsidiary (i) is in
default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both,
would result in a default by the Company or any Subsidiary under),
nor has the Company or any Subsidiary received notice of a claim
that it is in default under or that it is in violation of, any
indenture, loan or credit agreement or any other agreement or
instrument to which it is a party or by which it or any of its
properties is bound (whether or not such default or violation has
been waived), (ii) is in violation of any order of any court,
arbitrator or governmental body, or (iii) is or has been in
violation of any statute, rule or regulation of any
governmental authority, including without limitation all foreign,
federal, state and local laws applicable to its business and all
such laws that affect the environment, except in each case as could
not have or reasonably be expected to result in a Material Adverse
Effect.
Section 4.13 Regulatory
Permits . The Company and the Subsidiaries possess all
certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary
to conduct their respective businesses as described in the SEC
Reports, except where the failure to possess such permits could not
reasonably be expected to result in a Material Adverse Effect
(“ Material Permits ”), and neither the Company
nor any Subsidiary has received any notice of proceedings relating
to the revocation or modification of any Material
Permit.
Section 4.14 Title to Assets
. The Company and the Subsidiaries have good and marketable
title in fee simple to all real property owned by them and good and
marketable title in all personal property owned by them that is
material to the business of the Company and the Subsidiaries, in
each case free and clear of all Liens, except for Liens that do not
materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such
property by the Company and the Subsidiaries and Liens for the
payment of federal, state or other taxes, the payment of which is
neither delinquent nor subject to penalties. Any real
property and facilities held under lease by the Company and the
Subsidiaries are held
12
by them under valid,
subsisting and enforceable leases with which the Company and the
Subsidiaries are in compliance in all material respects.
Section 4.15 Patents and
Trademarks . The Company and the Subsidiaries have, or
have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets,
inventions, copyrights, licenses and other intellectual property
rights and similar rights necessary or material for use in
connection with their respective businesses as described in the SEC
Reports and which the failure to so have could have a Material
Adverse Effect (collectively, the “ Intellectual Property
Rights ”). Neither the Company nor any Subsidiary
has received a notice (written or otherwise) that any of the
Intellectual Property Rights used by the Company or any Subsidiary
violates or infringes upon the rights of any Person. To the
knowledge of the Company, all such Intellectual Property Rights are
enforceable and there is no existing infringement by another Person
of any of the Intellectual Property Rights. The Company and
its Subsidiaries have taken reasonable security measures to protect
the secrecy, confidentiality and value of all of their intellectual
properties, except where failure to do so could not, individually
or in the aggregate, reasonably be expected to have a Material
Adverse Effect.
Section 4.16 Insurance
. The Company and the Subsidiaries are insured by insurers of
recognized financial responsibility against such losses and risks
and in such amounts as are prudent and customary in the businesses
in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage at
least equal to the aggregate Subscription Amount. Neither the
Company nor any Subsidiary has any reason to believe that it will
not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business without a
significant increase in cost.
Section 4.17 Transactions With
Affiliates and Employees . Except as set forth in the SEC
Reports, none of the officers or directors of the Company and, to
the knowledge of the Company, none of the employees of the Company
is presently a party to any transaction with the Company or any
Subsidiary (other than for services as employees, officers and
directors), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for
rental of real or personal property to or from, or otherwise
requiring payments to or from any officer, director or such
employee or, to the knowledge of the Company, any entity in which
any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee or partner, in each
case in excess of $100,000 other than for (i) payment of
salary or consulting fees for services rendered,
(ii) reimbursement for expenses incurred on behalf of the
Company and (iii) other employee benefits, including stock
option agreements under any stock option plan of the
Company.
Section 4.18 Sarbanes-Oxley;
Internal Accounting Controls . The Company is in material
compliance with all provisions of the Sarbanes-Oxley Act of 2002
which are applicable to it as of the Closing Date. The
Company and the Subsidiaries maintain a system of internal
accounting controls sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with
management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to
maintain asset accountability, (iii) access to assets is
permitted only in accordance with
13
management’s
general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at
reasonable intervals and appropriate action is taken with respect
to any differences. The Company has established disclosure controls
and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the Company and
designed such disclosure controls and procedures to ensure that
information required to be disclosed by the Company in the reports
it files or submits under the Exchange Act is recorded, processed,
summarized and reported, within the time periods specified in the
SEC’s rules and forms. The Company’s
certifying officers have evaluated the effectiveness of the
Company’s disclosure controls and procedures as of the end of
the period covered by the Company’s most recently filed
periodic report under the Exchange Act (such date, the “
Evaluation Date ”). The Company presented in its
most recently filed periodic report under the Exchange Act the
conclusions of the certifying officers about the effectiveness of
the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Since the Evaluation Date, there
have been no changes in the Company’s internal control over
financial reporting (as such term is defined in the Exchange Act)
that has materially affected, or is reasonably likely to materially
affect, the Company’s internal control over financial
reporting.
Section 4.19 Certain Fees
. No brokerage or finder’s fees or commissions are or
will be payable by the Company to any broker, financial advisor or
consultant, finder, placement agent, investment banker, bank or
other Person with respect to the transactions contemplated by the
Transaction Documents. The Investor shall have no obligation
with respect to any fees or with respect to any claims made by or
on behalf of other Persons for fees of a type contemplated in this
Section that may be due in connection with the transactions
contemplated by the Transaction Documents.
Section 4.20 Private
Placement . Assuming the accuracy of the Investor
representations and warranties set forth in Article 5, no
registration under the Securities Act is required for the offer and
sale of the Purchased Securities by the Company to the Investor as
contemplated hereby. The issuance and sale of the Purchased
Securities hereunder does not contravene the rules and
regulations of the Trading Market.
Section 4.21 Investment
Company . The Company is not, and is not an Affiliate of,
and immediately after receipt of payment for the Securities, will
not be or be an Affiliate of, an “investment company”
within the meaning of the Investment Company Act of 1940, as
amended. The Company shall conduct its business in a manner
so that it will not become subject to the Investment Company Act of
1940, as amended.
Section 4.22 Registration
Rights . Other than pursuant to this Agreement, no Person
has any right to cause the Company to effect the registration under
the Securities Act of any securities of the Company, other than
registration statements which have already been filed and declared
effective or that have been filed and await declaration of
effectiveness by the SEC.
Section 4.23 Listing and
Maintenance Requirements . The Company’s Common
Stock is registered pursuant to Section 12(b) or
12(g) of the Exchange Act, and the Company has taken no action
designed to, or which to its knowledge is likely to have the effect
of, terminating the registration of the Common Stock under the
Exchange Act, nor has the Company received any notification that
the SEC is contemplating terminating such registration. The
Company has not,
14
in the 12 months
preceding the date hereof, received any notice from any Trading
Market on which the Common Stock is or has been listed or quoted to
the effect that the Company is not in compliance with the listing
or maintenance requirements of such Trading Market. The Company is,
and has no reason to believe that it will not in the foreseeable
future continue to be, in compliance with all such listing and
maintenance requirements.
Section 4.24 Application of
Takeover Protections . The Company and its b
|